Systems and methods are disclosed that facilitate providing guidance to a user during performance of a program or routine using a personalized avatar. In an aspect, a system includes a reception component configured to receive biochemical information about a physiological state or condition of a user, including information identifying a presence or a status of one or more biomarkers. The system further includes an analysis component configured to determine or infer one or more characteristics of the physiological state or condition of the user based on the information identifying the presence or the status of the one or more biomarkers, and a visualization component configured to adapt an appearance of an avatar presented to the user based on the one or more characteristics to reflect the one or more characteristics.

This disclosure features methods and compositions for treating diseases of the gastrointestinal tract with a TLR agonist.

The present invention provides an improved breath analyzer and breath test method to determine the presence of a gastrointestinal disorder in a human subject's digestive tract.

Systems and devices are described which include a tissue cutting device including a central rotatable shaft having a first end and a second end; a motor operably coupled to the first end of the central rotatable shaft, the motor including circuitry configured to rotate the central rotatable shaft; a moveable component configured to move along at least a portion of the length of the central rotatable shaft; and an elongated flexible cutting component having a first end and a second end, the first end of the elongated flexible cutting component secured to the moveable component and the second end of the elongated flexible cutting component secured to the central rotatable shaft in proximity to the second end of the central rotatable shaft; wherein movement of the moveable component along the at least a portion of the length of the central rotatable shaft changes a shape formed by the elongated flexible cutting component.

For measuring functionality of an orifice (16, 20) in the human pelvic region an elongated probe (4; 54) for insertion in the orifice (16, 20) is provided. The probe (4; 54) comprises one or more electrodes (5a-6a, 5b-6b, 6a-7a, 6b-7b; 55a-56a, 55b-56b, 56a-57a, 56b-57b, 57a-92a, 57b-92b) for stimulating receptors (23, 25) in tissue bounding the orifice (16, 20) and one or more muscle activity sensors (8a, 8b, 8c, 9a, 9b, 9c, 10a, 10b, 10c, 10d, 11a, 11b, 11e, 12a, 12b, 12c; 58a, 58b, 58c, 59a, 59b, 59c, 60a, 60b, 60c, 60d, 61a, 61b, 61c, 62) for sensing muscle activity causing pressure to be exerted by tissue bounding the orifice (16, 20). A control system (I) connected to the probe (4; 54) is arranged for outputting a neurostimulation signal (35) to the electrode or electrodes and for registering a pressure signal or signals from the pressure sensor or sensors during a time interval directly subsequent to the outputting of the neurostimulation signal.

A plastic optical fiber for a medical device lighting decreases the cost of a lens and simplify the design of a lighting apparatus, wherein the plastic optical fiber for a medical device includes a core composed of a (co)polymer containing methyl methacrylate as a main component and is characterized by including a cladding material composed of a copolymer having a fluorine weight composition ratio of 60 to 74%, and by having a theoretical numerical aperture, NA, of 0.48 to 0.65 and, thus, the plastic optical fiber has a high numerical aperture and also has excellent translucency and flexibility.

Methods, systems and devices for treating a patient include performing a first treatment to treat a first portion of tissue and performing a second treatment to treat a second portion of tissue. The second portion of tissue is treated at least twenty-four hours after the first portion of tissue is treated. In particular embodiments, the first portion of tissue includes duodenal tissue, and the second portion of tissue includes duodenal or other gastrointestinal tissue.

The present invention relates to a sampling device 100. The sampling device 100 comprises a separate compartment 110 that is ejected creating an increased space or volume for a sample to be stored. The sampling device 100 of the present invention is suitable for collecting a sample in an aquaculture environment, enclosed system or in the gastrointestinal tract of a human or an animal. The invention also relates to a method of orally administering the device 100 to an animal and recovering the device 100 and/or separate compartment 110 to carry out analysis on the collected sample for diagnosing the health of the gastrointestinal tract and determining nutrient absorption and digestibility.

An environment control system that controls an environment of a subject is provided. The environment control system includes an actuator configured to control an environment of a subject, and a controller configured to control an operation of the actuator. The environment control system includes an inference unit that includes a first learned model and a second learned model. The first learned model has been trained by associating environmental information indicating an environment of a subject with data correlating with one of sleep, excretion, movement, skin, and stress conditions of the subject. The second learned model has been trained by associating the data correlating with one of the sleep, excretion, movement, skin, and stress conditions of the subject with data correlating with a magnitude of one or more risks that may occur with respect to the subject in a future period of time. The environment control system includes an operating condition determining unit configured to, in a case in which data correlating with the magnitude of the one or more risks that may occur with respect to a subject in a future period of time is inferred based on the first and second learned model, evaluate the inferred data to determine an operating condition of the actuator.

A gastrointestinal treatment system including a gastrointestinal capsule adapted to treat a subject following ingestion of the gastrointestinal capsule. The gastrointestinal capsule includes: (a) a housing; (b) a vibrating agitator, powered by the battery, the vibrating agitator adapted such that, in a first vibrating mode of operation, the housing exerts vibrations on an environment surrounding the capsule; (c) a power supply disposed within the housing and adapted to power the vibrating agitator; and (d) a controller adapted, in response to receipt of an activation input, to activate the vibrating agitator to operate in the first vibrating mode of operation at at least one predetermined time of day. The system and method may be used to treat an ailment of the gastrointestinal tract and/or to mitigate at least one symptom of jetlag in a subject travelling from an origin location to a destination location.